Kiedy pacjent jest oporny na leczenie – historia dziewczynki z aplazją szpiku
© Borgis - Nowa Pediatria 2/2020, s. 23-25 | DOI: 10.25121/NP.2020.24.2.23
Izabela Marzec1, *Katarzyna Pawelec2
Summary
Acquired aplastic anemia (AAA) is a rare disease of the haematopoietic system in children. In the absence of a compatible family donor of bone marrow, immunosuppressive therapy is used in combination with anti-thymocytic globulin and cyclosporine.
We present a 6-year-old girl diagnosed with severe aplastic anemia (SAA), initially treated only with cyclosporine (CSA) due to lack of a drug in Ukraine. In 2 months of therapy, the child was admitted to a Polish clinic. Due to the persistence of aplasia, she received standard treatment with CSA and anti-lymphocyte globulin, to which she did not respond.
In view of disease progression and the lack of a completely compatible unrelated donor. It was decided to transplant from a 9/10 compatible donor, which was successful. Now the child is in remission of the disease and has 100% donor chimerism. Despite the difficulties in therapy, the girl has been healthy for over 2 years.
To jest tylko fragment artykułu. Aby przeczytać całość, przejdź do Czytelni medycznej.